Lichen China Ltd Enters Share Purchase Agreement
Ticker: LICN · Form: 6-K · Filed: Jul 18, 2024 · CIK: 1876766
| Field | Detail |
|---|---|
| Company | Lichen China LTD (LICN) |
| Form Type | 6-K |
| Filed Date | Jul 18, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $8,000,000, $3,000,000, $5,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-purchase-agreement, foreign-private-issuer, company-update
TL;DR
Lichen China Ltd signed a share purchase deal back in March 2023 with Zisu Zhou.
AI Summary
Lichen China Limited announced on July 18, 2024, that it entered into a Share Purchase Agreement on March 9, 2023, with Zisu Zhou, a national of the People's Republic of China, for the purchase of shares. The filing is a Report of Foreign Private Issuer for the month ended July 2024.
Why It Matters
This filing provides an update on a share purchase agreement, which could indicate changes in company ownership or strategic direction.
Risk Assessment
Risk Level: low — The filing is a routine report of a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Lichen China Limited (company) — Registrant
- Zisu Zhou (person) — Seller in Share Purchase Agreement
- March 9, 2023 (date) — Date of Share Purchase Agreement
- July 2024 (date) — Reporting Period
FAQ
What is the nature of the Share Purchase Agreement entered into by Lichen China Limited?
Lichen China Limited entered into a Share Purchase Agreement on March 9, 2023, with Zisu Zhou, a national of the People's Republic of China, who is identified as the Seller.
When was the Share Purchase Agreement originally entered into?
The Original Share Purchase Agreement was entered into on March 9, 2023.
Who is the seller in the Share Purchase Agreement?
The seller is Zisu Zhou, a national of the People's Republic of China.
What type of filing is this for Lichen China Limited?
This is a Form 6-K, Report of Foreign Private Issuer, for the month ended July 2024.
What is the principal executive office address for Lichen China Limited?
The address is 15th Floor, Xingang Square, Hubin North Road, Siming District, Xiamen City, Fujian Province, China, 361013.
Filing Stats: 416 words · 2 min read · ~1 pages · Grade level 13.3 · Accepted 2024-07-18 16:05:13
Key Financial Figures
- $8,000,000 — Target at the total purchase price of US$8,000,000. The Securities Purchase Agreements and
- $3,000,000 — Company has paid an initial deposit of $3,000,000 upon execution of the Original Share Pu
- $5,000,000 — ted the payment of remaining balance of $5,000,000. The transaction then has been closed.
Filing Documents
- ea0209632-6k_lichen.htm (6-K) — 12KB
- ea020963201ex10-1_lichen.htm (EX-10.1) — 22KB
- ea020963201ex10-2_lichen.htm (EX-10.2) — 21KB
- 0001213900-24-062548.txt ( ) — 55KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month ended July 2024 Commission File No. 001-41493 LICHEN CHINA LIMITED (Translation of registrant’s name into English) 15th Floor, Xingang Square, Hubin North Road, Siming District, Xiamen City, Fujian Province, China, 361013 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F Form 40-F Entry into Share Purchase Agreements On March 9, 2023, Lichen China Limited (the “Company”) entered into a Share Purchase Agreement (the “Original Share Purchase Agreement”) by and among Zisu Zhou, a People’s Republic of China national (the “Seller”), Bondly Enterprises Limited, a proprietary company registered in Hong Kong (the “Target”). The Target is engaged in professional education business. On July 12, 2024, the Company entered into a Supplemental Share Purchase Agreement (the “Supplemental Share Purchase Agreement”, together with the Original Share Purchase Agreement, the “Share Purchase Agreements”) by and among the Seller and the Target. Pursuant to the Supplemental Share Purchase Agreement, the Seller will be selling, and the Company will be purchasing, 60% of the equity interest of the Target at the total purchase price of US$8,000,000. The Securities Purchase Agreements and the transaction contemplated thereby, have been approved by the Company’s board of directors. The Company has paid an initial deposit of $3,000,000 upon execution of the Original Share Purchase Agreement. On July 17, 2024, the Company completed the payment of remaining balance of $5,000,000. The transaction then has been closed. The foregoing description of the Securities Purchase Agreements is qualified in its entirety by reference to the full text of the Share Purchase Agreement and Supplemental Share Purchase Agreement, which are filed as Exhibit 10.1 and Exhibit 10.2 to this Form 6-K respectively and is incorporated herein by reference. This current report on form 6-K is incorporated by reference into the Company’s registration statement on Form F-3 (File No. 333-277230 ). EXHIBIT INDEX Exhibit No. Description 10.1 Share Purchase Agreement 10.2 Supplemental Share Purchase Agreement 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Lichen China Limited Date: July 18, 2024 By: /s/ Ya Li Name: Ya Li Title Chief Executive Officer 2